The demand for transplant diagnostic products is anticipated to grow mainly due to factors such as the increasing burden of infectious diseases, growing public-private funding for target research activities, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. HLA typing for transplant market accounted for US$ 637.9 Million in 2020 and is estimated to be 1380.6 Million by 2029 and is anticipated to register a CAGR of 9.0%.

The report. "HLA Typing for Transplant Market, By Technology (Molecular Assay Technologies (PCR-Based Molecular Assays and Sequencing-based Molecular Assays) and Non-molecular Assay Technologies), By Product & Service (Reagents & Consumables, Instruments, and Software & Services), By Application (Diagnostic Applications (Antibody Screening, Chimerism Monitoring, and Others) and Research Applications), By End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029 ”

Key Highlights:

• In In February 2017, Immure, Inc., developed a new MIA FORA NGS FLEX HLA typing assay with the ability to withstand upto 11 HLA genes. This new typing assay provides high resolution solution without affecting performance. The new product will meet the demand of HLA testing community and also offer best quality transplant product line to customers, present in the market

Analyst View:

Growth in the number of transplantation procedures may enhance the market

Human leukocyte antigen (HLA) typing procedure is used to determine how closely tissue of donor matches with the tissue of recipient before transplantation. Human leukocyte antigens are proteins which inherited from the parents. Immune system utilizes HLA markers in order to recognize the location of cells inside the body and identify which cells belong to body and which do not. HLA matching helps in development and growth of new healthy blood cells and also reduces the risk of post-transplant complication.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “HLA Typing for Transplant Market”, Technology (Molecular Assay Technologies (PCR-Based Molecular Assays and Sequencing-based Molecular Assays) and Non-molecular Assay Technologies), By Product & Service (Reagents & Consumables, Instruments, and Software & Services), By Application (Diagnostic Applications (Antibody Screening, Chimerism Monitoring, and Others) and Research Applications), By End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029"

Key Market Insights from the report:        

HLA typing for transplant market accounted for US$ 637.9 Million in 2020 and is estimated to be 1380.6 Million by 2029 and is anticipated to register a CAGR of 9.0%. The market report has been segmented on the basis of technology, product & services, application, end-user, and region.

• By technology, in 2019, the molecular assay technologies segment estimated for highest share of the HLA typing for the transplants market. This is mainly attributed due to advantages offered by molecular assays such as high procedural efficacy, low turnaround time, real-time sample analysis, and the study of multiple samples.
• By product & services, the target market is segmented into reagents & consumables, instruments, and software & services.
• By application, the target market is segmented into diagnostic applications (antibody screening, chimerism monitoring, and others) and research applications
• By end-user, in 2019, independent reference laboratories estimated for highest share share of the HLA typing for the transplants market. This is mainly attributed due to rapid automation and modernization of diagnostic laboratories, increasing number of research & development activities outsourced by biotechnology & pharmaceutical companies to independent reference laboratories, and the rising number of organ transplantation procedures.
• By region, technologically developed nations in North America such as the U.S. and Canada estimates for the highest share of the global market due to growth in prevalence of chronic diseases such as cardiac, cancer, and renal associated diseases. However, growth in access and high utilization of advanced diagnostic technologies, technological advancements associated with HLA-based transplant diagnostics, and high growth have been registered in developing markets in Asia Pacific

Competitive Landscape:

The prominent player operating in the HLA typing for transplant market includes Thermo Fisher Scientific, Inc., CareDx, Inc., QIAGEN N.V., Illumina , Immucor, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Hologic, Inc., Luminex (US), and Biofortuna

The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com